Search

Search Results

• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.682

  2855

  PDF: 1419
• 

  Efficacy of high-dose methylprednisolone pulses in a child with noninfectious persistent pleuropericarditis revealing systemic juvenile idiopathic arthritis

  G. De Rosa, A. De Nisco, M. Piastra, P. Valentini, D. Rigante

  114-115

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.876

  1621

  PDF: 1500
• 

  Osteoporosis and rheumatic diseases

  N. Maruotti, A. Corrado, F.P. Cantatore

  125-135

  28-06-2014

  https://doi.org/10.4081/reumatismo.2014.785

  8512

  PDF: 3594

• PO:11:171 | Subcutaneous tocilizumab use in a young-onset mixed connective tissue disease patient with multiple treatment failures Rhaysa Araujo Mousinho¹, Elide Lupi², Massimiliano Limonta² | ¹Clinica di Reumatologia, Dipartimento di Medicina and ²Istituto di Anatomia Patologica, Dipartimento di Medicina di Laboratorio, Osp. S. M. della Misericordia, Università di Udine, Italy

  Società Italiana di Reumatologia

  26-11-2025

  https://doi.org/10.4081/reumatismo.2025.2154

  83
• 

  Uveitis in patients with oligoarticular juvenile idiopathic arthritis and juvenile spondyloarthritis/enthesitis related arthritis: is there any difference?

  A. Martins, S. Ganhão, F. Oliveira Pinheiro, C. Granjo Morais, M. Rodrigues, M. Leuzinger-Dias , L. Figueira, I. Brito

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1561

  1509

  PDF: 559
• 

  Serum KL-6 as predictive and prognostic marker of interstitial lung disease in childhood connective tissue diseases: a pilot study

  R. El-Beheidy, A.M. Domouky, H. Zidan, Y.A. Amer

  22-11-2021

  https://doi.org/10.4081/reumatismo.2021.1399

  6903

  PDF: 1084
• 

  Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran

  R. Assari, P. Sadeghi, A. Mirmohammadsadeghi, F. Ebadi, V. Ziaee

  189-198

  28-01-2020

  https://doi.org/10.4081/reumatismo.2019.1204

  1875

  PDF: 1009

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  https://doi.org/10.4081/reumatismo.2007.50

  1222

  PDF: 851